{"id":215,"date":"2014-03-21T10:42:36","date_gmt":"2014-03-21T15:42:36","guid":{"rendered":"http:\/\/leiferreport.com\/?p=215"},"modified":"2014-03-21T10:42:36","modified_gmt":"2014-03-21T15:42:36","slug":"weve-great-strides-treating-cancer-survivors","status":"publish","type":"post","link":"https:\/\/leifer.com\/?p=215","title":{"rendered":"We\u2019ve Made Great Strides in Treating Cancer, But Not Its Survivors"},"content":{"rendered":"<p><strong><span style=\"font-size: medium;\"><span style=\"font-family: Times New Roman;\"><span style=\"color: #000000;\"><a href=\"https:\/\/leifer.com\/wp-content\/uploads\/2014\/03\/iStock_000012884871Large.jpg\"><img loading=\"lazy\" decoding=\"async\" class=\"alignnone size-medium wp-image-216\" alt=\"iStock_000012884871Large\" src=\"http:\/\/leiferreport.com\/wp-content\/uploads\/2014\/03\/iStock_000012884871Large-400x266.jpg\" width=\"400\" height=\"266\" \/><\/a><\/span><\/span><\/span><\/strong><\/p>\n<h2><strong><span style=\"font-size: medium;\"><span style=\"font-family: Times New Roman;\">From Death Sentence to Chronic Disease:<\/span><\/span><\/strong><\/h2>\n<p><span style=\"font-size: medium;\"><span style=\"font-family: Times New Roman;\">Few words are more emotionally-laden than \u201ccancer.\u201d It does not merely connote disease, but rather suffering and death. Fortunately, not only the perception of cancer but the reality of the disease are changing rapidly thanks to early detection and advancements in treatment that render many cancers, at worst, a chronic illness, and at best curable. Proof can be readily seen in statistics from the American Cancer Society: \u201cThe 5-year relative survival rate for all cancers diagnosed between 2003 and 2009 is 68%, up from 49% in 1975-1977.\u201d<\/span><\/span><\/p>\n<p><span style=\"font-family: Times New Roman; font-size: medium;\">Of course, not all cancers have yielded to the advancements of medicine. Pancreatic <\/span><span style=\"font-family: Times New Roman; font-size: medium;\">cancer, metastatic melanoma, certain types of brain tumors, and other difficult diagnoses remain devastatingly difficult to treat. For some of these diseases, the differentiating variable is the stage at which they are diagnosed. Whereas there are excellent screening modalities for common cancers, such as breast and colon, other cancers, including ovarian, are often detected after they have metastasized to vital organs.<\/span><\/p>\n<p><span style=\"font-size: medium;\"><span style=\"font-family: Times New Roman;\">Nonetheless, the scales are tipping in favor of survivorship: \u201cWhile cancer incidence is projected to almost double over the next two decades to 21.4 million new cases annually, the number of people living with a history of cancer (i.e., \u2018survivors\u2019) is expected to triple to 75 million worldwide by 2030.\u201d <\/span><\/span><\/p>\n<h2><strong><span style=\"font-family: Times New Roman; font-size: medium;\">The Challenges of Survivorship:<\/span><\/strong><\/h2>\n<p><span style=\"font-family: Times New Roman; font-size: medium;\">Cancer survivors face a plethora of challenges \u2013 challenges that were unimaginable when they were originally diagnosed, and the focus was purely on ridding their bodies of the invading disease. Most patients have endured regimens in which their disease was cut-out, burned-out (with radiation), or \u201cpoisoned\u201d (with chemotherapy). Depending upon the extent of their treatment, there may be lingering or permanent side-effects\u2013 ranging from peripheral neuropathy to heart damage. Some patients are cognitively impaired from whole-brain radiation, and many others bear deep, but invisible emotionally scars from the journey.<\/span><\/p>\n<p><span style=\"font-size: medium;\"><span style=\"font-family: Times New Roman;\">McCabe et al. described the medical challenge facing cancer patients as follows: \u201cCancer survivors are at increased risk for long-term morbidity and premature mortality, related directly to the cancer itself, to preexisting comorbidities, and to exposure to therapy.\u201d As a result, cancer survivors need ongoing medical supervision by physicians who understand: 1) the specific treatment regimens that a patient received; 2) the outcome of these regimens; 3) the sequela of post-treatment side-effects that the patient is or may experience; 4) the patient\u2019s prognosis; 5) the recommended screening or monitoring activities to ensure that the cancer remains in check. <\/span><\/span><\/p>\n<h2><strong><span style=\"font-family: Times New Roman; font-size: medium;\">Who is My Doctor?<\/span><\/strong><\/h2>\n<p><span style=\"font-family: Times New Roman; font-size: medium;\">But exactly who provides such care in today\u2019 health system remains ambiguous, causing patients to fall through the proverbial \u201ccracks\u201d and not receive the care they need. \u00a0The Institute of Medicine stated that, \u201cFor patients, it can be a time of confusion both about what follow-up care involves and about which physician is responsible for follow-up care.\u201d The IOM also proffered a solution:\u00a0 \u201cPatients completing primary treatment should be provided with a comprehensive care summary and follow-up plan that is clearly and effectively explained.\u201d The report terms this as the \u201cSurvivorship Care Plan.\u201d <\/span><\/p>\n<p><span style=\"font-size: medium;\"><span style=\"font-family: Times New Roman;\">Sounds simple and logical \u2013 the patient receives a roadmap providing \u201ca summary of treatment and a specific detailed plan for surveillance follow-up and symptom management.\u201d However, there appear to be four impediments preventing this vitally important step from happening: 1) oncologists are not compensated for creating such plans; 2) the short supply of oncologists limits their ability to take time away from the active treatment of patients for the construction of such plans; 3) most cancer patients receive multi-modality treatment that occurs across disparate treatment sites \u2013 necessitating consensus on the part of the multiple specialists regarding the patients\u2019 care management plans; 4) oncologists are reluctant to facilitate transition of their patients to primary care physicians because they are less than convinced that PCPs have the clinical knowledge to properly manage cancer patients.<\/span><\/span><\/p>\n<h2><strong><span style=\"font-family: Times New Roman; font-size: medium;\">PCPs in Need of Respect:<\/span><\/strong><\/h2>\n<p><span style=\"font-family: Times New Roman; font-size: medium;\">In a study published in the <i>Journal of Family Medicine<\/i>, researchers found, \u201cthat a majority of PCPs perceive themselves as having an active role in the cancer-related follow-up care of survivors, most often in a co-management capacity with an oncologist. In contrast, most oncologists perceive that they directly provide cancer-related follow-up care themselves without much involvement from PCPs or other providers, a finding that parallels recent work documenting medical oncologists\u2019 limited engagement in co-managing breast cancer care.\u201d <\/span><\/p>\n<p><strong>A Call to Action<\/strong>:<\/p>\n<p><span style=\"font-family: Times New Roman; font-size: medium;\">Professional squabbles aside, the reality is that in fifteen years, there may be an additional 50 million cancer survivors. Just as medicine has made great strides in the early detection and treatment of cancer, now it must make comparable strides in addressing the profound needs of survivors. These hurdles to proper, ongoing care of cancer survivors must be overcome. Physicians need to be compensated for the time required to assemble detailed care plans, and primary care physicians must be appropriately educated to care for cancer survivors. <\/span><\/p>\n<p><span style=\"font-family: Times New Roman; font-size: medium;\">\u00a0<\/span><\/p>\n","protected":false},"excerpt":{"rendered":"<p>From Death Sentence to Chronic Disease: Few words are more emotionally-laden than \u201ccancer.\u201d It does not merely connote disease, but rather suffering and death. Fortunately, not only the perception of cancer but the reality of the disease are changing rapidly thanks to early detection and advancements in treatment that render many cancers, at worst, a [&hellip;]<\/p>\n","protected":false},"author":3,"featured_media":0,"comment_status":"open","ping_status":"open","sticky":false,"template":"","format":"standard","meta":{"_et_pb_use_builder":"","_et_pb_old_content":"","_et_gb_content_width":"","_exactmetrics_skip_tracking":false,"_exactmetrics_sitenote_active":false,"_exactmetrics_sitenote_note":"","_exactmetrics_sitenote_category":0,"footnotes":""},"categories":[3,9],"tags":[39,43,86,113,114],"class_list":["post-215","post","type-post","status-publish","format-standard","hentry","category-cancer","category-healthcare","tag-cancer-care","tag-cancer-survivors","tag-lack-of-care-for-survivors","tag-survivorship","tag-survivorship-care"],"_links":{"self":[{"href":"https:\/\/leifer.com\/index.php?rest_route=\/wp\/v2\/posts\/215","targetHints":{"allow":["GET"]}}],"collection":[{"href":"https:\/\/leifer.com\/index.php?rest_route=\/wp\/v2\/posts"}],"about":[{"href":"https:\/\/leifer.com\/index.php?rest_route=\/wp\/v2\/types\/post"}],"author":[{"embeddable":true,"href":"https:\/\/leifer.com\/index.php?rest_route=\/wp\/v2\/users\/3"}],"replies":[{"embeddable":true,"href":"https:\/\/leifer.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcomments&post=215"}],"version-history":[{"count":0,"href":"https:\/\/leifer.com\/index.php?rest_route=\/wp\/v2\/posts\/215\/revisions"}],"wp:attachment":[{"href":"https:\/\/leifer.com\/index.php?rest_route=%2Fwp%2Fv2%2Fmedia&parent=215"}],"wp:term":[{"taxonomy":"category","embeddable":true,"href":"https:\/\/leifer.com\/index.php?rest_route=%2Fwp%2Fv2%2Fcategories&post=215"},{"taxonomy":"post_tag","embeddable":true,"href":"https:\/\/leifer.com\/index.php?rest_route=%2Fwp%2Fv2%2Ftags&post=215"}],"curies":[{"name":"wp","href":"https:\/\/api.w.org\/{rel}","templated":true}]}}